The registry of tumors in lower animals
Ended Definitive Contract Awarded Last action
- Contract number
- 00261200209D261027034
- Awardee
-
Experimental Pathology Laboratories, Inc. UEI E4S8XBDQ4AN1
- Awarding agency
-
National Cancer Institute
National Institutes of Health, Department of Health and Human Services
- Obligated
- $2,146,321
Award facts
- Contract value 15% obligated
-
- $12,962,829.00 Current, with exercised options
- $14,573,033.00 Potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 493190 Other Warehousing and Storage
- Set-aside
- Total Small Business
- Competition
- Full and Open Competition · 1 offer
- Pricing
- Cost Plus Fixed Fee
- Place of performance
- Sterling, VA, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Other Administrative Action | -$1,205 | |
| Other Administrative Action | $0 | |
| Funding Only Action | $300,000 | |
| Other Administrative Action | $0 | |
| Funding Only Action | $126,170 | |
| Funding Only Action | $350,000 | |
| Other Administrative Action | $0 | |
| Funding Only Action | $467,279 | |
| Supplemental Agreement for work within scope | $0 | |
| Supplemental Agreement for work within scope | $459,077 | |
| Original award | $445,000 |
Show all 11
About this award
This is a definitive contract award by the National Cancer Institute (NCI), a civilian agency within the National Institutes of Health (NIH), to Experimental Pathology Laboratories, Inc. (EPL) for "The Registry of Tumors in Lower Animals" project. The $14,573,033.00 cost-plus-fixed-fee contract has a period of performance through September 29, 2007. EPL, a for-profit Subchapter S corporation registered in SAM.gov, is a contract research organization specializing in toxicology pathology services for federal agencies including the CDC, EPA, NIH, FDA, and Department of the Interior. The contract was set aside for small businesses. EPL has provided a range of specialized laboratory services such as microscopic evaluation, histopathological examination, and management of archives and repositories for government research programs on topics including viruses, aerosol exposures, and COVID-19.
Quick answers
Who was awarded contract 00261200209D261027034?
00261200209D261027034 was awarded to Experimental Pathology Laboratories, Inc. by National Cancer Institute (National Institutes of Health) on September 15, 2002.
How much is contract 00261200209D261027034 worth?
The government has obligated $2,146,321 on 00261200209D261027034. Its current value, with exercised options, is $12,962,829. Its potential value, with all options, is $14,573,033.
Was contract 00261200209D261027034 competed?
The extent of competition for 00261200209D261027034 was full and open competition. The government received 1 offer. It was set aside: Total Small Business.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award